Skip to content
Status last checked 25 August 2026 · always confirm against the official bill text before you act
Haven Access
Latest

← All bills

H.R. 8000

The END 7-OH Act - federal scheduling aimed squarely at 7-hydroxymitragynine.

We oppose this

END 7-OH Act

What it does

  • Referred to the House Committee on Energy and Commerce, and additionally to the Judiciary Committee.
  • Targets 7-hydroxymitragynine specifically rather than kratom generally.
  • Federal scheduling would reach every state at once, including states that have already written their own consumer protection acts.
  • Currently carries three cosponsors, all Republican.

What our model act does instead

We are not asking anyone to do nothing. Every objection below comes with the clause we would put in its place — the full text is here.

§13

No Alkaloid Caps; Mandatory Disclosure

7-OH is a naturally occurring kratom alkaloid and the metabolite your own liver produces from mitragynine. Section 13 treats potency as something to be measured and disclosed. Scheduling treats it as something to be removed - which does not change what is in the leaf, only what is legal to sell and test.

§10

Premarket Review for Novel Kratom Alkaloid Products

Where a product genuinely is novel, Section 10 provides premarket review - an assessment route rather than a prohibition, and one that does not sweep in the alkaloid profile of the plant itself.

If you call, say this

Yours will be better than ours because it is yours. Change a word, say where you live, and stop — ninety seconds is a long call.

I am a constituent and I am asking you to oppose H.R. 8000, the END 7-OH Act. 7-OH is a natural kratom alkaloid and it is what the body makes from kratom. Federal scheduling would override the consumer protection laws states have already passed and would move an entire market beyond the reach of any testing requirement. Please pursue labeling and testing standards instead.